Page 10 of 12 · 284 questions tagged bloodwork.
Conditions: HbA1c · eGFR · retatrutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can…
For reference: triglycerides · semaglutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…
The specifics, since they change the answer: cystatin C · semaglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan…
Concretely: HbA1c · twelve weeks · retatrutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
The case in front of me: magnesium · liraglutide. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would…
The case in front of me: ferritin · tirzepatide. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would…
Stated plainly: creatinine · mazdutide. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear…
Numbers first: ApoB · ferritin · tirzepatide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
I have the full paper rather than the abstract, and the supplementary appendix. I have the document in front of me and I can read the numbers. What I cannot do is…
The specifics, since they change the answer: cystatin C · three weeks · cagrilintide. An unexpected observation, and I would like a differential rather than…
The particulars: cystatin C · ecnoglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
Setup, so nobody has to ask: ALT · a GLP-1 receptor agonist. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I would like help reading this properly rather than being…
What I have: ApoB · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work matters.…
The specifics, since they change the answer: cystatin C · semaglutide. I am at the decision point and I would rather think it through than improvise. I would rather…
I have the full paper rather than the abstract, and the supplementary appendix. I can predict the outcome but I cannot explain it, which means I will get the next…
For reference: potassium · semaglutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement than…
I have three data points across nine months, which I hope is enough to see a trend. The comparison I want does not seem to exist anywhere in a form I can evaluate. I…
What I am working with: creatinine · a GLP-1 receptor agonist. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
What I have: ApoB · dulaglutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would still…
The case in front of me: GGT · liraglutide. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
Numbers first: ApoB · orforglipron. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would still…
Numbers first: eGFR · dulaglutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
The clinician who ordered the panel was not concerned; I would still like to understand it. The empirical answer seems settled. The explanation does not. If the…